Supplementary Table S2 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
Year: 2024
Type: supplementary-materials
Abstract: Mutect2 called and validated variants for each subject and each tumor region from whole exome sequencing data
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4402817474